Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential

Alessandra Gori1, Giulia Brindisi1, Maria Daglia2,3

  • 1Department of Mother-Child, Urological Science, Sapienza University of Rome, 00161 Rome, Italy.

Nutrients
|June 27, 2024
PubMed

Insights

Lactoferrin shows promise in managing childhood allergies by reducing inflammation and modulating immune responses. Further research is needed to fully understand its benefits for allergic children and their families.

Area of Science:

  • Immunology
  • Pediatrics
  • Biochemistry

Background:

  • Childhood allergic diseases are increasing, impacting quality of life.
  • Lactoferrin, a glycoprotein, possesses immunomodulatory properties.
  • Existing treatments for pediatric allergies have limitations.

Purpose of the Study:

  • To review the potential of lactoferrin as an immunomodulatory agent for childhood allergic diseases.
  • To explore lactoferrin's anti-inflammatory, antioxidant, and antimicrobial effects.
  • To highlight the need for further research on lactoferrin's role in pediatric allergy management.

Main Methods:

  • Literature review of studies on lactoferrin and allergic diseases in children.
  • Analysis of lactoferrin's biochemical and immunological functions.
  • Synthesis of current evidence regarding lactoferrin's therapeutic potential.

Main Results:

  • Lactoferrin exhibits significant anti-inflammatory and antioxidant activities.
  • Iron-binding capacity of lactoferrin may influence allergy symptom severity.
  • Antimicrobial properties of lactoferrin can prevent secondary infections.

Conclusions:

  • Lactoferrin demonstrates potential as an add-on therapy for pediatric allergic diseases.
  • Further research is crucial to confirm lactoferrin's efficacy and optimal use.
  • Harnessing lactoferrin could improve outcomes and quality of life for allergic children.

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
271
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
270
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
402
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
384
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
154
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K